U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira® (adalimumab)

17d ago

ALVO

PremiumPress Releases

U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira® (adalimumab)

17d ago

ALVO

PremiumPress Releases

Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimilar for Simponi® (golimumab)

23d ago

ALVO

PremiumPress Releases

Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimilar for Simponi® (golimumab)

23d ago

ALVO

More ALVO News >

ALVO News on the Web

2024-05-14

ScPharmaceuticals, Inc. (SCPH) Reports Q1 Loss, Lags Revenue Estimates

Zacks

Neutral

2024-05-13

Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Misses Revenue Estimates

Zacks

Neutral

2024-05-13

Alvotech Announces Webcast of First Quarter 2024 Financial Results on May 22, 2024, at 8:00 am EDT

Yahoo Finance

Neutral

2024-05-02

Alvotech Announces Participation at BofA Securities Healthcare Conference 2024

Yahoo Finance

Neutral

2024-05-01

Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors

CNBC

Neutral

2024-04-25

Gilead Sciences (GILD) Reports Q1 Loss, Tops Revenue Estimates

Zacks

Neutral

2024-04-24

Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimilar for Simponi®

Yahoo Finance

Neutral

2024-04-19

Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira®

Yahoo Finance

Neutral

News Score - Last 7 Days

Neutral

ALVO

Sector Average

Media Buzz

This Week3 articles

Weekly Average1.75 articles

News Sentiment

This Week50%

Sector Average62%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ALVO’s Media Buzz Sentiment?

3 articles about ALVO were published this week. In an average week, 1.75 articles are published.

What is ALVO’s weekly average amount of articles?

In an average week, 1.75 articles about ALVO are published.

What is ALVO’s News Sentiment?

50% of articles about ALVO were positive this week, compared to its sector average of 62%.

Healthcare Stocks that are Trending in the News

PYXSPyxis Oncology

EPIXESSA Pharma

STXSStereotaxis

CABACabaletta Bio

TLPHTalphera

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing